logo
episode-header-image
Jan 7
13m 17s

Gastric Cancer Worldwide

JAMA NETWORK
About this episode
tail spinning
Up next
Jan 12
A Conversation About the FDA's Regulation of Mifepristone
Mifepristone used with misoprostol is the most common abortion regimen in the US. It is also a focal point of reproductive health policy and politics, with controversy over its legal status and regulation by the US Food and Drug Administration (FDA). Author G. Caleb Alexander, MD ... Show More
20m 47s
Dec 30
JAMA Editors' Choice 2025: Clinical Reviews Podcasts
JAMA Deputy Editor Mary McDermott, MD, and JAMA Deputy Editor Kristin Walter, MD, MS, highlight their selections of top JAMA Clinical Reviews podcasts in 2025. Related Content: Managing Adverse Effects of Obesity Medications Diagnosis and Management of Hypothyroidism Type 2 Diabe ... Show More
16m 47s
Dec 26
From the JAMA Network: JAMA Research of the Year With Editor in Chief Kirsten Bibbins-Domingo
In this episode, JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and Medical News Director Jennifer Abbasi discuss the journal's inaugural Research of the Year roundup. Related Content: Research of the Year 2025 
16m 8s
Recommended Episodes
Sep 2019
National Obesity Care Week with Dr. Chandra
Join Dr. Chandra as she discusses the importance of understanding the risks of obesity and how we can address the disease during National Obesity Care Week. 
3m 34s
Feb 2025
America’s Obesity Crisis: Is Ozempic a Cure or a Cover-Up? | Calley Means and Tyna Moore
The rise in obesity and chronic disease over the years is alarming. Rather than genetics, it can be attributed to environmental and dietary changes, emphasizing the role of food quality over quantity. And while GLP-1 agonists like Ozempic may show some promise in addressing metab ... Show More
1h 2m
Jul 2025
122 | How to Support Patients on Obesity Medications: A Short Course on Side Effects, Satiety & Supplements
<p><a href='https://www.examroomnutrition.com/course'>Join The Obesity Medicine Nutrition Course</a>! Enter code POD15 at checkout for 15% off!</p><p>Anti-obesity medications are everywhere—but they also come with new challenges. From rapid weight loss and side effects to TikTok- ... Show More
29m 21s
Oct 2024
#320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape
tail spinning
20m 36s
Oct 2024
#537: Appetite Regulation, Metabolic Compensation and More – Stephan Guyenet, PhD
<p>This is an "ask me anything" (AMA) episode with Dr. Stephan Guyenet, an expert in obesity neuroscience and eating behavior. <strong>This episode was originally published on <a href="https://sigmanutrition.com/premium/" target= "_blank" rel="noreferrer noopener follow" data-wpe ... Show More
1h 4m
Jul 2024
Tara Swart (Neuroscientist): The Science Behind Stress, Body Fat & Manifestation (E273)
<p>In this episode, respected neuroscientist and author Dr. Tara Swart joins Jake to uncover fascinating perspectives about the complex interplay between our brains and bodies.</p><br><p>Tara sheds light on how our constant smartphone use impacts us both mentally and physically, ... Show More
56m 42s
Dec 2024
How Ozempic Transformed the Way We Look at Obesity
Ozempic, Wegovy, and Mounjaro, are being called “miracle drugs” with users boasting about their fast results. Dr. Sanjay Gupta takes a deep dive into how they disrupted the entire weight loss industry and changed the conversation about obesity.  Learn more about your ad choices. ... Show More
23m 47s
May 2024
#323: The Hidden Risks of Weight-Loss Drugs: Behind the GLP-1 Hype with Ragen Chastain
Writer, speaker, and weight-inclusive health/fitness professional Ragen Chastain joins us to discuss the potential side effects and other downsides of using GLP-1 drugs (like Ozempic and its ilk) for weight loss, the massive influence the manufacturers of these drugs are having o ... Show More
38m 48s
Jul 2024
379. SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle
CardioNerds (Drs. Gurleen Kaur and Richard Ferraro) and episode FIT Lead Dr. Saahil Jumkhawala (Cardiology Fellow at the University of Miami) discuss SGLT inhibitors, focusing on the biology of SGLT and its inhibition, with Dr. Katherine Tuttle (Executive Director for Research at ... Show More
33m 24s
Mar 2024
Is obesity a choice?
Globally, 650 million people meet the threshold for obesity. With those numbers on the rise, we ask: Is obesity a matter of individual choice, or is it rooted in larger systemic problems? Greg Doucette, a bodybuilder and health coach, says that obesity is a choice, and argues tha ... Show More
31m 56s
Listen to millions of songs and podcasts on Anghami